Michigan Medicine Laboratories, the reference laboratory division of Michigan Medicine, continues to serve the community with flexible options for fast, high-quality COVID-19 testing, including a convenient new testing location.
The North Carolina Society of Pathologist (NCSP) is having their annual 2021 meeting virtually this year. With this year's focus on pulmonary pathology, Dr. Jeffrey Myers was invited to be the key note speaker.
Join us in recognizing patient safety awareness week by reviewing our critical values policy. Download our flyer that shows the importance of critical values and how they can affect the lives of patients. And finally, if you are a client and looking for an instructional video for the critical values survey, please find that video link below.
U-M was recently ranked No. 9 among institutions globally in cancer research, according to the U.S. News & World Report 2021 Best Global University Rankings.
The detection of DDIT3 rearrangements can be useful in diagnosing myxoid liposarcoma – including uncommon histologic variants – and in distinguishing this sarcoma from other mesenchymal tumors that may be considered in the differential diagnosis.
Michigan Medicine named The Best and Brightest Companies to Work For®. A competition that identifies and honors organizations that display a commitment to excellence in their human resource practices and employee enrichment.
In an effort to ensure the safety of our faculty and staff, while maintaining service excellence for our clients and mutual patients, Michigan Medicine Laboratories (MLabs) has updated our tissue submission requirements.
We have changed our location for COVID testing to an inside drive through to Huron Valley Ambulance Center (HVA).
We are pleased to welcome Dr. Evan Farkash as the new section chief for Renal Pathology as of September 1, 2020.
MLabs is now offering PDL-1 testing for Metastatic triple-negative breast cancer (TNBC) whose tumors express PD-L1.